Trusted brands in one place
Clinically proven for weight loss
Doctor-guided programs
No in-person appointments needed
Trusted brands in one place
Clinically proven for weight loss
Doctor-guided programs
No in-person appointments needed

Explore GLP-1's
News & Updates

Learn more about GLP'-1's latest news & updates

Explore By Category

All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
GLP-1 Drugs and Obesity Care: What Clinicians Still Question
Patient Guides

GLP-1 Drugs and Obesity Care: What Clinicians Still Question

GLP-1 medications like semaglutide and tirzepatide are changing how doctors treat obesity, but major clinical questions remain unanswered. This article breaks down what clinicians are debating, what it means for patients, and how to have smarter conversations with your provider.

Read More
Body Changes on GLP-1s: How to Talk About It
Patient Guides

Body Changes on GLP-1s: How to Talk About It

GLP-1 medications like semaglutide and tirzepatide are reshaping how millions of people look and feel. But the social conversations around these changes can be just as challenging as the physical ones. This guide helps you understand what to expect and how to talk about it on your own terms.

Read More
GLP-1 Friendly Menus: What to Know
Nutrition & Diet

GLP-1 Friendly Menus: What to Know

Restaurants are rolling out "GLP-1 friendly" menu options as more Americans take weight-loss medications like semaglutide and tirzepatide. But what does that label actually mean for patients? Here's a practical guide to navigating dining out while on a GLP-1 medication.

Read More
Why You Feel Sick on GLP-1s (It's Not Always the Drug)
Side Effects & Safety

Why You Feel Sick on GLP-1s (It's Not Always the Drug)

Many people on GLP-1 medications like Ozempic, Wegovy, and Zepbound experience nausea, fatigue, and other symptoms that feel medication-related but often have other causes. Understanding the difference helps you stay on track without unnecessary suffering. This guide breaks down what's really going on and what you can do about it.

Read More
GLP-1 Drugs May Lower TB Risk in Diabetes
Science & How It Works

GLP-1 Drugs May Lower TB Risk in Diabetes

New research suggests GLP-1 receptor agonists may reduce the risk of tuberculosis in people with type 2 diabetes, adding to a growing list of health benefits beyond blood sugar and weight control. Here is what the findings mean for patients currently taking or considering semaglutide or tirzepatide, and what questions to bring to your doctor.

Read More
Copycat GLP-1 Drugs: What You Need to Know
Patient Guides

Copycat GLP-1 Drugs: What You Need to Know

Compounded "copycat" versions of GLP-1 drugs like semaglutide and tirzepatide have flooded the market at a fraction of the brand-name price. But cheaper isn't always simpler. Here's what every patient should understand before choosing a compounded option.

Read More
Novo Nordisk vs. Eli Lilly GLP-1 Ad Lawsuit Explained
News & Updates

Novo Nordisk vs. Eli Lilly GLP-1 Ad Lawsuit Explained

Novo Nordisk has filed a lawsuit against Eli Lilly over advertising claims related to their GLP-1 medications. This legal battle between two pharmaceutical giants could affect how patients and pharmacists understand these drugs. Here's what you need to know and why it matters for your treatment decisions.

Read More
GLP-1 Meds and Addiction: What the Research Shows
Science & How It Works

GLP-1 Meds and Addiction: What the Research Shows

Research is building around an unexpected pattern: people taking GLP-1 medications for weight loss are reporting reduced cravings for alcohol, nicotine, and other addictive substances. Here is what the current science shows, what it means for patients, and the questions worth asking your doctor.

Read More
Hanmi's Eppe: New GLP-1 Rival to Wegovy and Mounjaro
News & Updates

Hanmi's Eppe: New GLP-1 Rival to Wegovy and Mounjaro

Hanmi Pharmaceutical is preparing to launch Eppe, a Korean-made GLP-1 weight loss medication that could put real pricing pressure on Wegovy and Mounjaro. Here's what patients currently researching or taking GLP-1 medications should understand about this new competitor and what it might mean for costs.

Read More